IDNA icon

iShares Genomics Immunology and Healthcare ETF
IDNA

Overview Fund Activity

48 hedge funds and large institutions have $43.7M invested in iShares Genomics Immunology and Healthcare ETF in 2020 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+11
Holders Change %
+29.73%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
20
Increased
12
Reduced
5
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
UBS Group
UBS Group
Switzerland
+$3.41M
2
SWM
Strategic Wealth Management
Washington
+$1.77M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.06M
4
WAP
Wealthcare Advisory Partners
Pennsylvania
+$961K
5
LPL Financial
LPL Financial
California
+$919K

Top Sellers

1
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
-$6.28M
2
RCS
Retirement Capital Strategies
California
-$5.91M
3
Jane Street
Jane Street
New York
-$1.17M
4
SFS
Sowell Financial Services
Arkansas
-$616K
5
PAG
Private Advisor Group
New Jersey
-$314K
Name Holding Trade Value Shares
Change 		Shares
Change %
SFS
51
Sowell Financial Services
Arkansas
– -$616K -16,231 Closed
PAG
52
Private Advisor Group
New Jersey
– -$314K -8,275 Closed
TA
53
TCG Advisors
Texas
– -$280K -7,374 Closed
AAS
54
Avantax Advisory Services
Texas
– -$208K -5,491 Closed
LC
55
Lindbrook Capital
California
– -$15K -400 Closed
BWM
56
Baystate Wealth Management
Massachusetts
– -$9K -238 Closed
OPS
57
Orion Portfolio Solutions
Nebraska
– -$1K -30 Closed
1 2
3